Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Cottin

Showing results (311-320 of 468) with videos related to

Pageof 47
Sort By:
Plos One|August 14, 2013
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian populationRaphael Borie, Bruno Crestani, Philippe Dieude, et al.
Respiratory Medicine and Research|April 23, 2026
Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosisVincent Cottin, Bruno Crestani, Carole Planès, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 24, 2015
Severe hematologic complications after lung transplantation in patients with telomerase complex mutationsRaphael Borie, Caroline Kannengiesser, Sandrine Hirschi, et al.
The European Respiratory Journal|October 27, 2012
The pathogenesis of pulmonary fibrosis: a moving targetWim A Wuyts, Carlo Agostini, Katerina M Antoniou, et al.
Respiratory Research|December 31, 2024
Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi studyAthol U Wells, Simon L F Walsh, Ayodeji Adegunsoye, et al.
The European Respiratory Journal|October 21, 2017
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertensionAthénaïs Boucly, Vincent Cottin, Hilario Nunes, et al.
Respirology (Carlton, Vic.)|October 3, 2025
Molecular Investigation in Early-Onset Interstitial Lung Disease: Results From 699 Unrelated PatientsCamille Louvrier, Nadia Nathan, Vincent Cottin, et al.
ERJ Open Research|April 9, 2026
Efficacy and safety of danazol for pulmonary fibrosis or bone-marrow failure associated with telomere-related gene mutationFlore Sicre de Fontbrune, Stéphane Jouneau, Vincent Cottin, et al.
ERJ Open Research|October 26, 2019
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide surveyCatharina C Moor, Marlies S Wijsenbeek, Elisabetta Balestro, et al.
Pageof 47

Showing results (311-320 of 468) with videos related to

Sort By:
Pageof 47
Plos One|August 14, 2013
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian populationRaphael Borie, Bruno Crestani, Philippe Dieude, et al.
Respiratory Medicine and Research|April 23, 2026
Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosisVincent Cottin, Bruno Crestani, Carole Planès, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 24, 2015
Severe hematologic complications after lung transplantation in patients with telomerase complex mutationsRaphael Borie, Caroline Kannengiesser, Sandrine Hirschi, et al.
The European Respiratory Journal|October 27, 2012
The pathogenesis of pulmonary fibrosis: a moving targetWim A Wuyts, Carlo Agostini, Katerina M Antoniou, et al.
Respiratory Research|December 31, 2024
Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi studyAthol U Wells, Simon L F Walsh, Ayodeji Adegunsoye, et al.
The European Respiratory Journal|October 21, 2017
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertensionAthénaïs Boucly, Vincent Cottin, Hilario Nunes, et al.
Respirology (Carlton, Vic.)|October 3, 2025
Molecular Investigation in Early-Onset Interstitial Lung Disease: Results From 699 Unrelated PatientsCamille Louvrier, Nadia Nathan, Vincent Cottin, et al.
ERJ Open Research|April 9, 2026
Efficacy and safety of danazol for pulmonary fibrosis or bone-marrow failure associated with telomere-related gene mutationFlore Sicre de Fontbrune, Stéphane Jouneau, Vincent Cottin, et al.
ERJ Open Research|October 26, 2019
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide surveyCatharina C Moor, Marlies S Wijsenbeek, Elisabetta Balestro, et al.
Pageof 47